Capmatinib and gefitinib combination therapy: will EGFR-mutated MET-dysregulated NSCLC "capitulate"?
Transl Lung Cancer Res
.
2018 Dec;7(Suppl 4):S321-S325.
doi: 10.21037/tlcr.2018.12.05.
Authors
Brian Ko
1
,
Balazs Halmos
2
Affiliations
1
Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
2
Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY 10461, USA.
PMID:
30705845
PMCID:
PMC6328688
DOI:
10.21037/tlcr.2018.12.05
No abstract available
Publication types
Editorial
Comment